查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1890926

勝任細胞市場：依細胞類型、生物、應用、感受態程度、最終使用者和地區分類

Competent Cells Market, By Cell Type, By Organism Type, By Application, By Competency Level, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，勝任細胞市值將達到 24.7 億美元，到 2032 年將達到 48.7 億美元，2025 年至 2032 年的複合年成長率為 10.2%。

報告內容 報告詳情
基準年： 2024 2025年市場規模： 24.7億美元
歷史數據時期： 2020年至2024年 預測期： 2025年至2032年
預測期（2025-2032年）複合年成長率： 10.20% 2032 年的預測值： 48.7億美元

全球勝任細胞市場在生物技術和製藥產業佔據重要地位，是分子生物學應用和基因工程過程中不可或缺的基礎工具。勝任細胞是指經過化學或物理處理，使其對DNA具有更高滲透性的細菌細胞，使研究人員能夠透過轉化過程導入外源遺傳物質。這些特化的細胞在克隆、蛋白質表現、質體擴增以及各種重組DNA技術中發揮著至關重要的作用，而這些技術正是現代生物技術研發的基礎。

該市場涵蓋多種勝任細胞，包括勝任細胞感受態細胞和勝任細胞，這些細胞專為從常規克隆到高效轉化等特定應用而設計。在基因組學研究的拓展、個人化醫療的進步以及生物技術創新的推動下，全球對可靠和高效的勝任細胞系統的需求持續成長。學術研究機構、製藥公司、生物技術公司和受託研究機構（CRO）是主要的終端用戶，他們不斷需要分子克隆工具和基因工程技術來促進治療方法開發和科學研究的突破性發現，從而推動了市場成長。

市場動態

全球勝任細胞市場受多種關鍵促進因素推動，這些因素正促進其在研究和商業應用領域的擴張。基因體學和蛋白質體學研究投入的不斷成長，以及遺傳疾病日益增多，亟需創新療法，是推動市場發展的關鍵因素。合成生物學方法、CRISPR-Cas9基因編輯技術以及個人化醫療舉措的日益普及，顯著提升了對高品質勝任細胞的需求，這些細胞能夠進行複雜的基因操作。此外，生物技術產業的擴張，尤其是在新興經濟體，為市場滲透和產生收入創造了巨大的機會。然而，也存在一些顯著的限制因素，例如嚴格的法律法規結構對基因研究和生物技術應用進行監管，這可能導致產品核可延遲，並增加製造商的合規成本。

維持低溫運輸物流和儲存所需的高成本對勝任細胞的科研機構而言構成額外挑戰，尤其對於預算有限的小規模科研機構而言更是如此。此外，處理勝任細胞的技術複雜性和專業知識要求也可能限制經驗不足的研究人員採用此技術。儘管有這些限制，但藥物發現和開發項目的日益普及、將研究活動外包給受託研究機構（CRO）的趨勢日益成長，以及勝任細胞在包括生質燃料生產和藥品製造在內的工業生物技術過程中的廣泛應用，都創造了巨大的機遇，並有望推動市場持續成長。

本次調查的主要特點

  • 本報告對全球勝任細胞市場進行了詳細分析，以 2024 年為基準年，給出了預測期（2025-2032 年）內的市場規模（十億美元）和復合年成長率（%）。
  • 它還重點介紹了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、阻礙因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
  • 本報告根據以下參數對全球勝任細胞市場的主要企業進行了分析：公司概況、產品系列、主要特徵、財務績效和策略。
  • 本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球勝任細胞市場報告的目標受眾是該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過全球勝任細胞市場分析中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、監理及趨勢分析

  • 市場動態
  • 促進要素
  • 抑制因素
  • 機會
  • 影響分析
  • 重大進展
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特分析
  • 併購趨勢
  • 產業趨勢

4. 2020-2032年全球勝任細胞市場（依細胞類型分類）

  • 化學勝任細胞
  • 勝任細胞
  • 超強勝任細胞

5. 2020-2032年全球勝任細胞市場（依生物種類分類）

  • 細菌勝任細胞
  • 酵母勝任細胞
  • 哺乳動物勝任細胞

6. 2020-2032年全球勝任細胞市場依應用領域分類

  • 分子克隆和亞克隆
  • 重組蛋白表達
  • 質體和文庫建構（cDNA、基因組、噬菌體、BAC/YAC文庫）
  • 突變和定向進化
  • CRISPR/Cas 與基因組編輯工作流程
  • 合成生物學和代謝工程
  • 病毒載體建構與包裝支持
  • 其他應用（例如，功能基因體學、路徑篩檢）

7. 2020-2032年全球能力水準勝任細胞市場

  • 高效勝任細胞
  • 中效勝任細胞
  • 低效率勝任細胞

8. 2020-2032年全球勝任細胞市場（依最終用戶分類）

  • 學術和研究機構
  • 生物技術和生物製藥公司
  • 合約研究組織（CRO）
  • 診斷與臨床研究實驗室
  • 工業微生物學和合成生物學公司
  • 政府和非營利研究機構

9. 2020-2032年全球勝任細胞市場

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第10章 競爭格局

  • Thermo Fisher Scientific Inc
  • Merck KGaA Sigma Aldrich
  • Agilent Technologies Inc
  • Takara Bio Inc
  • New England Biolabs Inc
  • Promega Corporation
  • QIAGEN NV
  • Zymo Research Corp
  • Bio Rad Laboratories Inc
  • GenScript Biotech Corporation
  • OriGene Technologies Inc
  • Lucigen brand of LGC Biosearch Technologies
  • HiMedia Laboratories Pvt Ltd
  • Intact Genomics Inc
  • Scarab Genomics LLC

第11章 分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第12章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI8959

Competent Cells Market is estimated to be valued at USD 2.47 Bn in 2025 and is expected to reach USD 4.87 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.47 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.20% 2032 Value Projection: USD 4.87 Bn

The global competent cells market represents a critical segment within the biotechnology and pharmaceutical industry, serving as fundamental tools for molecular biology applications and genetic engineering processes. Competent cells are bacterial cells that have been chemically or physically treated to increase their permeability to DNA, enabling researchers to introduce foreign genetic material through transformation procedures. These specialized cells play an indispensable role in cloning, protein expression, plasmid propagation, and various recombinant DNA technologies that form the backbone of modern biotechnology research and development.

The market encompasses various types of competent cells, including chemically competent cells and electrocompetent cells, each designed for specific applications ranging from routine cloning to high-efficiency transformations. With the expanding scope of genomics research, personalized medicine initiatives, and biotechnology innovations, the demand for reliable and efficient competent cell systems continues to surge globally. Academic research institutions, pharmaceutical companies, biotechnology firms, and contract research organizations constitute the primary end users driving market growth through their continuous need for molecular cloning tools and genetic manipulation technologies that facilitate breakthrough discoveries in therapeutic development and scientific research.

Market Dynamics

The global competent cells market is propelled by several key drivers that collectively fuel its expansion across research and commercial applications. The increasing investment in genomics and proteomics research, coupled with the growing prevalence of genetic disorders requiring innovative therapeutic solutions, serves as a primary growth catalyst for market advancement. The rising adoption of synthetic biology approaches, CRISPR-Cas9 gene editing technologies, and personalized medicine initiatives significantly amplifies the demand for high-quality competent cells capable of facilitating complex genetic manipulations. Additionally, the expanding biotechnology sector, particularly in emerging economies, creates substantial opportunities for market penetration and revenue generation. However, the market faces notable restraints including stringent regulatory frameworks governing genetic research and biotechnology applications, which can delay product approvals and increase compliance costs for manufacturers.

The high cost associated with maintaining cold chain logistics and storage requirements for competent cells poses additional challenges, particularly for smaller research institutions with limited budgets. Furthermore, the technical complexity involved in handling competent cells and the requirement for specialized expertise may limit adoption among novice researchers. Despite these constraints, significant opportunities emerge from the increasing focus on drug discovery and development programs, the growing trend of outsourcing research activities to contract research organizations, and the expanding applications of competent cells in industrial biotechnology processes including biofuel production and pharmaceutical manufacturing, positioning the market for sustained growth trajectory.

Key Features of the Study

  • This report provides in-depth analysis of the global competent cells market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global competent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Merck KGaA Sigma Aldrich, Agilent Technologies Inc, Takara Bio Inc, New England Biolabs Inc, Promega Corporation, QIAGEN NV, Zymo Research Corp, Bio Rad Laboratories Inc, GenScript Biotech Corporation, OriGene Technologies Inc, Lucigen brand of LGC Biosearch Technologies, HiMedia Laboratories Pvt Ltd, Intact Genomics Inc, and Scarab Genomics LLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global competent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global competent cells market

Market Segmentation

  • Cell Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Chemically Competent Cells
    • Electrocompetent Cells
    • Ultracompetent Cells
  • Organism Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Bacterial Competent Cells
    • Yeast Competent Cells
    • Mammalian Competent Cells
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Molecular Cloning and Subcloning
    • Recombinant Protein Expression
    • Plasmid and Library Construction (cDNA, genomic, phage, BAC/YAC libraries)
    • Mutagenesis and Directed Evolution
    • CRISPR/Cas and Genome Editing Workflows
    • Synthetic Biology and Metabolic Engineering
    • Viral Vector Construction and Packaging Support
    • Other Applications (e.g., functional genomics, pathway screening)
  • Competency Level Insights (Revenue, USD Bn, 2020 - 2032)
    • High Efficiency Competent Cells
    • Moderate Efficiency Competent Cells
    • Low Efficiency Competent Cells
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Academic and Research Institutes
    • Biotechnology and Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Diagnostic and Clinical Research Laboratories
    • Industrial Microbiology and Synthetic Biology Companies
    • Government and Non-Profit Research Organizations
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific Inc
    • Merck KGaA Sigma Aldrich
    • Agilent Technologies Inc
    • Takara Bio Inc
    • New England Biolabs Inc
    • Promega Corporation
    • QIAGEN NV
    • Zymo Research Corp
    • Bio Rad Laboratories Inc
    • GenScript Biotech Corporation
    • OriGene Technologies Inc
    • Lucigen brand of LGC Biosearch Technologies
    • HiMedia Laboratories Pvt Ltd
    • Intact Genomics Inc
    • Scarab Genomics LLC

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Competent Cells Market, By Cell Type
    • Global Competent Cells Market, By Organism Type
    • Global Competent Cells Market, By Application
    • Global Competent Cells Market, By Competency Level
    • Global Competent Cells Market, By End User
    • Global Competent Cells Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Competent Cells Market, By Cell Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Chemically Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Electrocompetent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ultracompetent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Competent Cells Market, By Organism Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Bacterial Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Yeast Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mammalian Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Competent Cells Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Molecular Cloning and Subcloning
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Recombinant Protein Expression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Plasmid and Library Construction (cDNA, genomic, phage, BAC/YAC libraries)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mutagenesis and Directed Evolution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • CRISPR/Cas and Genome Editing Workflows
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Synthetic Biology and Metabolic Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Viral Vector Construction and Packaging Support
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Applications (e.g., functional genomics, pathway screening)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Competent Cells Market, By Competency Level, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • High Efficiency Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Moderate Efficiency Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Low Efficiency Competent Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Competent Cells Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biotechnology and Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic and Clinical Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Industrial Microbiology and Synthetic Biology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Government and Non-Profit Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Competent Cells Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Organism Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Competency Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Thermo Fisher Scientific Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA Sigma Aldrich
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takara Bio Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zymo Research Corp
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio Rad Laboratories Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GenScript Biotech Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • OriGene Technologies Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lucigen brand of LGC Biosearch Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HiMedia Laboratories Pvt Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Intact Genomics Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Scarab Genomics LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us